Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model

Current Pharmaceutical Design

Volumn 14, Issue 3, 2008, Pages 221-225

  Vannini, Nicola ^a,b   Pfeffer, Ulrich ^c   Lorusso, Girieca ^a,d   Noonan, Douglas M ^b   Albini, Adriana ^a  

^a IRCCS MULTIMEDICA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Aging; Angiogenesis; Apoptosis; Cancer; Cardiovascular; Endothelium; Senescence

Indexed keywords

ACETYLCYSTEINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; RESVERATROL; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL AGING; CELL PROLIFERATION; DOWN REGULATION; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; METASTASIS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; TISSUE REGENERATION; VASCULAR ENDOTHELIUM; ANIMAL; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ACETYLCYSTEINE; ANIMALS; APOPTOSIS; CELL AGING; E-SELECTIN; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER;

EID: 39749086955     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208783413248     Document Type: Review

References (50)

1. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002; 2(10): 727-39.
2. Jakobsson L, Kreuger J, Claesson-Welsh L. Building blood vessels-stem cell models in vascular biology. J. Cell Biol 2007; 177(5): 751-5.
3. Tettamanti G, Malagoli D, Benelli R, Albini A, Grimaldi A, Perletti G, et al. Growth factors and chemokines: A comparative functional approach between invertebrates and vertebrates. Curr Med Chem 2006; 13(23): 2737-50.
4. Winn RK, Harlan JM. The role of endothelial cell apoptosis in inflammatory and immune diseases. J Thromb Haemost 2005; 3(8): 1815-24.
5. Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res 2005; 66(2): 286-94.
6. d'Alessio P. Aging and the endothelium. Exp Gerontol 2004; 39(2): 165-71.
7. Lum H, Hao Z, Gayle D, Kumar P, Patterson CE, Uhler MD. Vascular endothelial cells express isoforms of protein kinase A inhibitor. Am J Physiol Cell Physiol 2002; 282(1): C59-66.
8. Fukuda MN, Ohyama C, Lowitz K, Matsuo O, Pasqualini R, Ruoslahti E, et al. A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. Cancer Res 2000; 60(2): 450-6.
9. Fuster MM, Brown JR, Wang L, Esko JD. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Res 2003; 63(11): 2775-81.
10. Katayama Y, Hidalgo A, Chang J, Peired A, Frenette PS. CD44 is a physiological E-selectin ligand on neutrophils. J Exp Med 2005; 201(8): 1183-9.
11. Munro JM. Endothelial-leukocyte adhesive interactions in inflammatory diseases. Eur Heart J 1993; 14(Suppl K): 72-7.
12. Zerfaoui M, Fukuda M, Sbarra V, Lombardo D, El-Battari A. alpha(1,2)-fucosylation prevents sialyl Lewis x expression and E-selectin-mediated adhesion of fucosyltransferase VII-transfected cells. Eur J Biochem 2000; 267(1): 53-61.
13. Gonzalez-Gay MA, Garcia-Unzueta MT, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, et al. Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis. Clin Exp Rheumatol 2006; 24(4): 373-9.
14. Edelstein LC, Pan A, Collins T. Chromatin modification and the endothelial-specific activation of the E-selectin gene. J Biol Chem 2005; 280(12): 11192-202.
15. Garcia-Criado FJ, Lozano FS, Barros MB, Parreno FC, Fresnadillo MJ, Garcia-Sanchez JE, et al. P- and E-selectin blockade can control bacterial translocation and modulate systemic inflammatory response. J Invest Surg 2005; 18(4): 167-76.
16. Ghersa P, Whelan J, Cambet Y, DeLamarter JF, Hooft van Huijsduijnen R. Distamycin prolongs E-selectin expression by interacting with a specific NF-kappaB-HMG-I(Y) binding site in the promoter. Nucleic Acids Res 1997; 25(2): 339-46.
17. Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A, Ungvari Z. Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: Role of NF-kappaB inhibition. Am J Physiol Heart Circ Physiol 2006; 291(4): H1694-9.
18. Schubert SY, Neeman I, Resnick N. A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants. FASEB J 2002; 16(14): 1931-3.
19. Zou Y, Jung KJ, Kim JW, Yu BP, Chung HY. Alteration of soluble adhesion molecules during aging and their modulation by calorie restriction. FASEB J 2004; 18(2): 320-2.
20. Bullard DC, Kunkel EJ, Kubo H, Hicks MJ, Lorenzo I, Doyle NA, et al. Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J Exp Med 1996; 183(5): 2329-36.
21. Frenette PS, Mayadas TN, Rayburn H, Hynes RO, Wagner DD. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 1996; 84(4): 563-74.
22. Kunkel EJ, Ley K. Distinct phenotype of E-selectin-deficient mice. E-selectin is required for slow leukocyte rolling in vivo. Circ Res 1996; 79(6): 1196-204.
23. Milstone DS, Fukumura D, Padgett RC, O'Donnell PE, Davis VM, Benavidez OJ, et al. Mice lacking E-selectin show normal numbers of rolling leukocytes but reduced leukocyte stable arrest on cytokine-activated microvascular endothelium. Microcirculation 1998; 5(2-3). 153-71.
24. Xu D, Neville R, Finkel T. Homocysteine accelerates endothelial cell senescence. FEBS Lett 2000; 470(1): 20-4.
25. Shojaei F, Ferrara N. Antiangiogenesis to treat cancer and intraocular neovascular disorders. Lab Invest 2007; 87(3): 227-30.
26. Kerbel RS, Kamen BA. The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer 2004; 4(6): 423-36.
27. Albini A, Noonan DM, Ferrari N. Molecular pathways for cancer angioprevention. Clin Cancer Res 2007; in press.
28. Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 2007; 7(2): 139-47.
29. Noonan DM, Benelli R, Albini A. Angiogenesis and cancer prevention: A vision. Recent Results Cancer Res 2007; 174: 219-24.
30. Jain RK. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 2005; 307(5706): 58-62.
31. Tosetti F, Ferrari N, De Flora S, Albini A. Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J 2002; 16(1): 2-14.
32. De Flora S, Izzotti A, D'Agostini F, Balansky RM, Noonan D, Albini A. Multiple points of intervention in the prevention of cancer and other mutation-related diseases. Mutat Res 2001; 480-481: 9-22.
33. Dell'Eva R, Ambrosini C, Minghelli S, Noonan DM, Albini A, Ferrari N. The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-{kappa}B pathway. Carcinogenesis 2007; 28(2): 404-13.
34. Albini A, Dell'Eva R, Vene R, Ferrari N, Buhler DR, Noonan DM, et al. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. Faseb J 2006; 20(3): 527-9
35. Fassina G, Vene F, Morini M, Minghelli S, Benelli R, Noonan DM, et al. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin Cancer Res 2004; 10(14): 4865-73.
36. Bachmeier B, Nerlich A, Iancu C, Cilli M, Schleicher E, Vene R, et al. The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem 2007; 19(1-4): 137-52.
37. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005; 7(3): 211-7.
38. Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet 2001; 357(9255): 539-45.
39. Dimitroff CJ, Lechpammer M, Long-Woodward D, Kutok JL. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res 2004; 64(15): 5261-9.
40. De Flora S, D'Agostini F, Masiello L, Giunciuglio D, Albini A. Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models. Int J Cancer 1996; 67(6): 842-8.
41. Albini A, Morini M, D'Agostini F, Ferrari N, Campelli F, Arena G, et al. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine. Cancer Res 2001; 61(22): 8171-8.
42. Cai T, Fassina G, Morini M, Aluigi MG, Masiello L, Fontanini G, et al. N-acetylcysteine inhibits endothelial cell invasion and angiogenesis. Lab Invest 1999; 79(9): 1151-9.
43. Aluigi MG, De Flora S, D'Agostini F, Albini A. Fassina G. Anti-apoptotic and antigenotoxic effects of N-acetylcysteine in human cells of endothelial origin. Anticancer Res 2000; 20(5A): 3183-7.
44. Pfeffer U, Ferrari N, Dell'eva F, Indraccolo S, Morini M, Noonan DM, et al. Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells: Microarray gene expression analyses. Mutat Res 2005; 591(1-2): 198-211.
45. Litwin M, Clark K, Noack L, Furze J, Berndt M, Albelda S, et al. Novel cytokine-independent induction of endothelial adhesion molecules regulated by platelet/endothelial cell adhesion molecule (CD31). J Cell Biol 1997; 139(1): 219-28.
46. Luo J, Paranya G, Bischoff J. Noninflammatory expression of E-selectin is regulated by cell growth. Blood 1999; 93(11): 3785-91.
47. Pammer J, Reinisch C, Birner P, Pogoda K, Sturzl M, Tschachler E. Interferon-alpha prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continuous stimulation. Lab Invest 2006; 86(10): 997-1007.
48. Frick M, Weidinger F. Endothelial function: A surrogate endpoint in cardiovascular studies? Curr Pharm Des 2007; 13(17): 1741-50.
49. Glantzounis GK, Yang W, Koti RS, Mikhailidis DP, Seifalian AM, Davidson HR. The role of thiols in liver ischemia-reperfusion injury. Curr Pharm Des 2006; 12(23): 2891-901.
50. Martin J, Collot-Teixeira S, McGregor L, McGregor JL. The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes. Curr Pharm Des 2007; 13(17): 1751-9.